We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
-4.82%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
+$65.2M
Cap. Flow
+$156M
Cap. Flow %
13.1%
Top 10 Hldgs %
5.3%
Holding
1,418
New
379
Increased
331
Reduced
358
Closed
311

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$10.5M
2
MMM icon
3M
MMM
+$6.83M
3
GILD icon
Gilead Sciences
GILD
+$6.68M
4
ROKU icon
Roku
ROKU
+$6.41M
5
DOCU
DocuSign
DOCU
+$6.09M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$5.8M
2
MRVL icon
Marvell Technology
MRVL
+$5.73M
3
VRNS icon
Varonis Systems
VRNS
+$5.65M
4
SLB icon
SLB Ltd
SLB
+$5.57M
5
CHGG icon
Chegg
CHGG
+$5.43M

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Industrials 13.7%
3 Healthcare 13.14%
4 Consumer Discretionary 12.77%
5 Financials 11.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLMD
1076
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$55K ﹤0.01%
18,531
-26,961
-59% -$59.3K
LVO icon
1077
LiveOne
LVO
$57.2M
$54K ﹤0.01%
6,624
– –
VHC icon
1078
VirnetX Holding Corp
VHC
$63.9M
$53K ﹤0.01%
1,629
+3
+0.2% +$123
NOVN
1079
DELISTED
Novan, Inc. Common Stock
NOVN
$50K ﹤0.01%
+12,622
New +$46.4K
DAKT icon
1080
Daktronics
DAKT
$1.06B
$49K ﹤0.01%
12,812
-1,413
-10% -$6.49K
VATE icon
1081
INNOVATE Corp
VATE
$106M
$46K ﹤0.01%
+1,254
New +$46.5K
PHAS
1082
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$45K ﹤0.01%
33,808
-29
-0.1% -$47
PLXP
1083
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$44K ﹤0.01%
+10,786
New +$59.1K
BGRY
1084
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$43K ﹤0.01%
15,008
-140,068
-90% -$499K
LSF icon
1085
Laird Superfood
LSF
$45.6M
$42K ﹤0.01%
+11,615
New +$79K
BHIL
1086
DELISTED
Benson Hill, Inc.
BHIL
$42K ﹤0.01%
+371
New +$51.3K
LVOX
1087
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$41K ﹤0.01%
13,521
-4,010
-23% -$17.6K
ONCT
1088
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$38K ﹤0.01%
1,364
– –
EVGN icon
1089
Evogene
EVGN
$7.64M
$34K ﹤0.01%
2,583
– –
GMBL
1090
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$34K ﹤0.01%
1
– –
TAST
1091
DELISTED
Carrols Restaurant Group, Inc.
TAST
$32K ﹤0.01%
+14,200
New +$36.5K
GORO icon
1092
Goldgroup Mining Inc.
GORO
$163M
$31K ﹤0.01%
13,697
-150
-1% -$278
COMS
1093
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$31K ﹤0.01%
369
– –
EMWP
1094
DELISTED
Eros Media World PLC
EMWP
$31K ﹤0.01%
+11,184
New +$46.6K
EPZM
1095
DELISTED
Epizyme, Inc
EPZM
$31K ﹤0.01%
27,347
+11,384
+71% +$18.6K
LPTH icon
1096
Lightpath Technologies
LPTH
$753M
$30K ﹤0.01%
14,993
– –
GNLN icon
1097
Greenlane Holdings
GNLN
$1.23M
– –
0
– –
ELTX icon
1098
Elicio Therapeutics
ELTX
$83.8M
$27K ﹤0.01%
1,280
-90
-7% -$2.03K
YCBD icon
1099
cbdMD
YCBD
$6.19M
$27K ﹤0.01%
73
– –
GASS icon
1100
StealthGas
GASS
$318M
$26K ﹤0.01%
10,698
– –
42 43
44
45 46

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Occudo Quantitative Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Occudo Quantitative Strategies held 1,418 positions worth $1.19B, up 5.8% from $1.13B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Occudo Quantitative Strategies deployed $156M of net new capital in Q1 2022, opening 379 new positions and adding to 331 existing holdings. Its largest new stake was Kodiak Sciences: 267,985 shares worth $2.07M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Chegg, an estimated $5.43M trimmed.

  • Occudo Quantitative Strategies's largest Q1 2022 buy was Kodiak Sciences: 267,985 shares worth $2.07M.
  • Occudo Quantitative Strategies added most to Sherwin-Williams in Q1 2022, an estimated $6.05M increase.
  • Occudo Quantitative Strategies's biggest Q1 2022 reduction was Chegg, cutting an estimated $5.43M.
  • Occudo Quantitative Strategies fully exited Intercontinental Exchange in Q1 2022, selling an estimated $5.8M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.3% of its $1.19B portfolio in Q1 2022.
  • Occudo Quantitative Strategies opened 379 new positions and closed 311 in Q1 2022.
  • Occudo Quantitative Strategies's portfolio value rose 5.8% quarter-over-quarter to $1.19B.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.